Axsome Therapeutics Forecast and Stock Analysis
Technical AXSM stock analysis for April 22, 2019.
Axsome Therapeutics gained 0.53% in the last trading day, rising from $15.01 to $15.09 , and has now gained 3 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. The price has risen in 6 of the last 10 days and is up by 4.07% over the past 2 weeks. Volume has increased in the last day along with the price, which is a positive technical sign, and, in total, 84 082 more shares were traded than the day before. In total, 986 998 shares bought and sold for approximately $14.89 million.
Close price at the end of the last trading day (Monday, 22nd Apr 2019) of the AXSM stock was $15.09. This is 0.53% more than the trading day before Thursday, 18th Apr 2019.
During day the stock fluctuated 6.03% from a day low at $14.60 to a day high of $15.48.
30 day high of the AXSM stock price was $16.80 and low was $12.76.
90 day high was $16.80 and low was $7.63.
52 week high for the Axsome Therapeutics - $16.80 and low - $1.94.
Axsome Therapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 70.69% during the next 3 months and, with 90% probability hold a price between $21.16 and $32.02 at the end of this period.
Only positive signals in the chart today. Axsome Therapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $14.59 and $12.76. A break down below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday April 17, 2019, which indicates further gains until a new top pivot has been found. Volume is rising along with the price. This is considered to be a good technical signal.
Relative Strength Index (RSI)
RSI14 is 64 and the stock is currently not being overbought or oversold
Support & Resistance
Axsome Therapeutics finds support from accumulated volume at $14.61.
This stock may move much during a day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.88 between high and low, or 6.03%. For the last week, the stock has had a daily average volatility of 9.27%.
Our recommended stoploss: $14.20 (-5.89%) (This stock has medium daily movements and this gives medium risk. There is a buy signal from pivot bottom found 2 days ago.)
Very Low Low Medium High Very High
Evaluation: Buy Candidate
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for this stock to perform well in the short-term.
|Golden Star Signal|
Get competitive edge
The signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star.
This signal is rare and, in most cases, gives a very good return. From 8.000 stocks usually only a few will trigger a Golden Star Signal per day!
Get access to Golden Star list now
|AXSM $15.09 ($0.08 0.53%)|
AXSM is up $0.08 today, but where's it headed in 2019?
|Zacks Investment Research is releasing its prediction for AXSM based on the 1-3 month system that more than doubles the S&P 500.
This report is free today for StockInvest.us readers.
Click here – the AXSM analysis is free »
From Our Blog
- Trading With Moving Average
- Pivot Points
- Accumulated Volume - Support and Resistance
- Volume - The Indicator You Really Need to Know
- We Give Back!
- Better Buy: Amazon vs. Facebook
- Better Buy: Apple vs. Microsoft
- Relative Strength Index (RSI)
- How to Lose Money When Trading: Part 2
- How to Lose Money When Trading: A Trader is Born
- Our 2017 Christmas Donation
- The Golden Star
- Announcing Partnership With CityFALCON
- Why correct moving average matters
- NASDAQ down -4.17%. Our portfolio is up +8.56%
- New Feature Added: Golden Star Signal
- Pick a Winner With StockInvest.us